Literature DB >> 19521425

Nevoid basal cell carcinoma syndrome with cleft lip and palate associated with the novel PTCH gene mutations.

Ryo Sasaki1, Kayoko Saito, Yorikatsu Watanabe, Yoshinaga Takayama, Katsunori Fujii, Kaori Agawa, Toshiyuki Miyashita, Tomohiro Ando, Tanetaka Akizuki.   

Abstract

Nevoid basal cell carcinoma syndrome (NBCCS) is a rare autosomal dominant disorder characterized by developmental abnormalities and a predisposition to cancers. Two unrelated patients, 21- and 16-year-old males, with cleft lip and palate and multiple jaw cysts, were diagnosed according to clinical criteria. To confirm a diagnosis of NBCCS, we undertook a molecular genetic analysis of the PTCH gene. Their PTCH genes were analyzed by direct sequencing of the PCR product from their DNA, and previously unreported mutations were identified. A heterozygous duplication at the nucleotide position between 3325 and 3328 of the PTCH gene (c.3325_3328dupGGCG) was detected in the 21-year-old patient. It caused a frameshift mutation, resulting in a premature termination of the PTCH protein. A point mutation (G to C) in intron 7 of the PTCH gene (c.1067+1G>C) was detected in the 16-year-old patient. This caused an aberrant splicing of PTCH. It is interesting to note that the non-canonical cryptic splice-donor site was activated, which did not conform to the GT-AG rule.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19521425     DOI: 10.1038/jhg.2009.51

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  2 in total

1.  A novel INDEL mutation in the PTCH1 gene in a Chinese family with Gorlin syndrome.

Authors:  Zhuoya Huang; Yongan Zhou; Xiaoxia Fu; Aiping Kou; Hairong Fu; Han Xiao; Ying Jin; Zhonghua Zhao
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01

2.  Constitutive activation of hedgehog signaling adversely affects epithelial cell fate during palatal fusion.

Authors:  Jingyuan Li; Yuan Yuan; Jinzhi He; Jifan Feng; Xia Han; Junjun Jing; Thach-Vu Ho; Jian Xu; Yang Chai
Journal:  Dev Biol       Date:  2018-07-05       Impact factor: 3.582

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.